Clinical Trial Update: Diffuse Optical Monitoring With Inhaled Nitric Oxide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating diffuse optical monitoring with inhaled nitric oxide for stroke; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Steven Messe | Conditions: Stroke | Phase 2 | Status: ACTIVE_NOT_RECRUITING